| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |